ARCHIVES

NCCN in Transition: New Strategy to Examine Role of Informatics, Revenue Sources and International Programs

This article is from The Cancer Letter archive.

Vol. 38 No. 24 | June 15, 2012

Download PDF Visit The Full Archive

Related Articles

White House To Appoint Richard Klausner, Molecular Biologist, As NCI’s 11th Director

July 28, 1995

FDA News: Tentative Approval Given IVAX Paxene; BMS Exclusivity Upheld

January 9, 1998

FDA Approves Rituxan For NHL With CHOP Therapy

February 24, 2006

WHO Names Brinker As Goodwill Ambassador

May 29, 2009

Regional Groups: Why 15 Were Not Among Those Funded; Cancer Regional Studies Review Committee Chartered

July 2, 1982

McKenna Sees Budget Cuts as Threat to Year 2000 Goals Urges Stepped Up Efforts Against Tobacco Industry

April 5, 1985